Q1 2024 13F Holders as of 3/31/2024
-
Type / Class
-
Equity / COMMON STOCK
-
Shares outstanding
-
152M
-
Number of holders
-
541
-
Total 13F shares, excl. options
-
157M
-
Shares change
-
+1.25M
-
Total reported value, excl. options
-
$11B
-
Value change
-
+$73.3M
-
Put/Call ratio
-
1.05
-
Number of buys
-
259
-
Number of sells
-
-227
-
Price
-
$70.39
Significant Holders of BIO-TECHNE Corp - COMMON STOCK (TECH) as of Q1 2024
610 filings reported holding TECH - BIO-TECHNE Corp - COMMON STOCK as of Q1 2024.
BIO-TECHNE Corp - COMMON STOCK (TECH) has 541 institutional shareholders that have filed 13F forms with the Securities Exchange Commission (SEC).
These institutions hold a total of 157M shares
.
Largest 10 shareholders include VANGUARD GROUP INC (18.3M shares), BlackRock Inc. (17.7M shares), STATE STREET CORP (6.37M shares), PRICE T ROWE ASSOCIATES INC /MD/ (5.75M shares), BAMCO INC /NY/ (5M shares), MORGAN STANLEY (4.19M shares), GEODE CAPITAL MANAGEMENT, LLC (3.84M shares), NEUBERGER BERMAN GROUP LLC (3.57M shares), DF DENT & CO INC (3.4M shares), and AMERIPRISE FINANCIAL INC (3.28M shares).
This table shows the top 541 institutional shareholders of the company equity. This data is sourced directly from the SEC via 13F filings.
| Investor |
Option |
Weight % |
Change % |
Value $ |
* Price $ |
Shares |
Share Change |
Activity |
Report Period |
* Reported Price is the price of the security as of the portfolio date. This value is significant in that it is the last known price at which the security was still held.
An asterisk sign (*) next to the price indicates that the price is likely invalid.